For its first quarter, which ended on Sept. 30, the company reported that net sales of biomaterials products were $12.6 million, compared to $12.7 million in the comparable period last year.
Orthopedic sales, primarily of sports medicine and spine products, fell from $8.0 million to $6.4 million, and within that figure, net sales of spine products fell $1.0 million to $2.7 million.
Read the release on Kensey Nash’s quarterly sales.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
